Global /South Korea /Healthcare /Biotechnology /200780

BCWORLD PHARM. Co., Ltd.

200780

• KRX: 200780 • Delayed

4,445KRW -0.5%

2.91 USD

As of 13 June 2026, BCWORLD PHARM. Co., Ltd. has a market cap of $27.25M USD, ranking #34904 globally and #2175 in South Korea. It ranks #3148 in the Healthcare sector, and #605 in the Biotechnology industry.

Global Rank

34904

Country Rank

2175

Sector Rank

3148

Industry Rank

605

Key Stats

Market Cap

$27.25MUSD

41.45B KRW

Enterprise Value

$80.61MUSD

123.02B KRW

Revenue (TTM)

$49.84MUSD

75.8B KRW

EBITDA (TTM)

$6.52MUSD

9.95B KRW

Net Income (TTM)

-$3.22MUSD

-4.9B KRW

EBITDA Margin

13%

Profit Margin

-6.5%

PS Ratio

0.5

PB Ratio

0.6

EV/EBITDA

12.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Sung-Han Hong open_in_new

Employees

280

Founded

1980

Website

bcwp.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.5%	-3.6%	-7.4%	-11%	5.7%	-19%	-0.6%	-19%	-71%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	200780 (주)비씨월드제약 ISIN: KR7200780005 Shares Out.: Shares Outstanding: 10.221M¹ Shares Float: 5.799M² TV: TradingView: KRX: 200780 SA: Stock Analysis: KRX: 200780 YF: Yahoo Finance: 200780.KS GF: Google Finance: KRX: 200780 BA: Barron's: 200780 MS: Morningstar: XKRX: 200780	4,445 KRW	TV: TradingView: KRX: 200780 SA: Stock Analysis: KRX: 200780 YF: Yahoo Finance: 200780.KS GF: Google Finance: KRX: 200780 BA: Barron's: 200780 MS: Morningstar: XKRX: 200780

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About BCWORLD PHARM. Co., Ltd.

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 164K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 103K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.37B 20.33T KRW 49K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.51B 8.37T KRW 20K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.99B 6.07T KRW 15K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.25B 3.42T KRW 8K%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 669K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 587K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 175K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 155K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 155K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 101K%	-	United States

chevron_leftBack